Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(7%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
7%
Ph not_applicable
6
43%
Ph phase_2
1
7%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
1(12.5%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(9)
Terminated(1)
Other(3)

Detailed Status

Completed9
unknown3
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (12.5%)
Phase 21 (12.5%)
N/A6 (75.0%)

Trials by Status

completed964%
withdrawn17%
active_not_recruiting17%
unknown321%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials

All 14 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
14